| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 DNAH3 MYH6 MYH7 MYH8 DNAH2 MYO18A DNAH1 SMC3 MYO18B DNAH5 DYNC1H1 | 3.91e-12 | 118 | 147 | 13 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 DNAH3 MYH6 MYH7 MYH8 HYOU1 ANXA5 DNAH2 MYO18A HSP90AA5P DDX1 DNAH1 SMC3 SMARCA1 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 TOP2A DYNC1H1 RAD17 | 2.18e-11 | 614 | 147 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GIPC1 MYH1 EPS8 MYH2 MYH6 MYH7 MYH8 DCDC1 ANK1 CETN2 AXL SPTA1 IFT81 NUMA1 MYO18A NEB SPC24 SYNE3 DST ALMS1 SMC3 TLN1 MACF1 LIMCH1 TRAK2 DIAPH3 DMD MYO18B | 7.17e-09 | 1099 | 147 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | GIPC1 MYH1 EPS8 MYH2 MYH6 MYH7 MYH8 SPTA1 MYO18A NEB SYNE3 DST TLN1 MACF1 LIMCH1 DIAPH3 DMD MYO18B | 1.58e-08 | 479 | 147 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH6 MYH7 MYH8 SPTA1 MYO18A NEB SYNE3 TLN1 MACF1 MYO18B | 1.21e-07 | 227 | 147 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.60e-07 | 18 | 147 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 MYH7 MYH8 DNAH2 MYO18A HSP90AA5P DDX1 SMC3 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 DYNC1H1 RAD17 | 1.69e-07 | 441 | 147 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.73e-06 | 28 | 147 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.28e-06 | 37 | 147 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.34e-06 | 38 | 147 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.28e-05 | 70 | 147 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | myosin binding | 3.90e-05 | 85 | 147 | 6 | GO:0017022 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 6.18e-05 | 11 | 147 | 3 | GO:1990814 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.01e-04 | 145 | 147 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | annealing activity | 1.34e-04 | 14 | 147 | 3 | GO:0140666 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 MYH7 MYH8 DNAH2 MYO18A HSP90AA5P NUDT13 DDX1 SMC3 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 DYNC1H1 RAD17 | 1.52e-04 | 839 | 147 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 MYH7 MYH8 DNAH2 MYO18A HSP90AA5P NUDT13 DDX1 SMC3 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 DYNC1H1 RAD17 | 1.54e-04 | 840 | 147 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 MYH7 MYH8 DNAH2 MYO18A HSP90AA5P NUDT13 DDX1 SMC3 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 DYNC1H1 RAD17 | 1.54e-04 | 840 | 147 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.61e-04 | 3 | 147 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 MYH7 MYH8 DNAH2 MYO18A HSP90AA5P DDX1 SMC3 ACIN1 MACF1 ASCC3 DNAH5 HSPA1L HSPA9 DYNC1H1 RAD17 | 1.94e-04 | 775 | 147 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.03e-04 | 73 | 147 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.10e-04 | 40 | 147 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 3.47e-04 | 19 | 147 | 3 | GO:1990825 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.58e-04 | 127 | 147 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP GIPC1 ANXA7 SH3GL1 POSTN DST YKT6 TLN1 PAK2 MACF1 KDR DIAPH3 DMD | 4.95e-04 | 599 | 147 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 5.31e-04 | 5 | 147 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.33e-04 | 262 | 147 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | cadherin binding | 9.33e-04 | 339 | 147 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.29e-03 | 428 | 147 | 10 | GO:0015631 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.32e-03 | 163 | 147 | 6 | GO:0031072 | |
| GeneOntologyMolecularFunction | DNA-directed 5'-3' RNA polymerase activity | 1.37e-03 | 30 | 147 | 3 | GO:0003899 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.38e-03 | 111 | 147 | 5 | GO:0003727 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MED20 AXL BCR ITK POLR3G JAK3 POLR1D BMX MAPK14 DCLK3 MASTL PAK2 POLL KDR MAPK13 EPHA5 | 1.52e-03 | 938 | 147 | 16 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | AXL BCR ITK JAK3 BMX MAPK14 DCLK3 MASTL PAK2 KDR MAPK13 EPHA5 | 1.64e-03 | 600 | 147 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | 5'-3' RNA polymerase activity | 1.66e-03 | 32 | 147 | 3 | GO:0034062 | |
| GeneOntologyMolecularFunction | RNA polymerase activity | 1.66e-03 | 32 | 147 | 3 | GO:0097747 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.05e-03 | 308 | 147 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 2.07e-03 | 73 | 147 | 4 | GO:0001786 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 2.10e-03 | 122 | 147 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 2.83e-03 | 11 | 147 | 2 | GO:0098505 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 2.83e-03 | 11 | 147 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MED20 MYO18A DDX1 POLR3G POLR1D LIG4 NSUN3 SMARCA1 POLL ASCC3 TOP2A RAD17 | 2.97e-03 | 645 | 147 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.89e-03 | 43 | 147 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | vinculin binding | 3.98e-03 | 13 | 147 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 3.98e-03 | 13 | 147 | 2 | GO:0043047 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.01e-06 | 15 | 145 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH6 MYH7 CETN2 CEP162 IFT81 DZIP1L NUMA1 DNAH2 OBSL1 NEB DNAH1 CCDC13 AKAP4 ALMS1 SMC3 CEP83 RPGR SCFD1 DIAPH3 DNAH5 DYNC1H1 RUFY4 CFAP46 | 4.54e-06 | 1138 | 145 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | actin filament-based process | EPS8 MYH2 MYH6 MYH7 MYH8 SPTA1 SH3GL2 MYO18A OBSL1 APOA1 NEB BCR GPD1L ALMS1 TLN1 PAK2 LIMCH1 DIAPH3 MYO18B EPHA5 | 6.22e-06 | 912 | 145 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 6.64e-06 | 18 | 145 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 7.60e-06 | 239 | 145 | 10 | GO:0031032 | |
| GeneOntologyBiologicalProcess | synaptic vesicle uncoating | 1.17e-05 | 7 | 145 | 3 | GO:0016191 | |
| GeneOntologyBiologicalProcess | microtubule-based process | DNAH3 CETN2 ANXA5 IFT81 NUMA1 DNAH2 OBSL1 DNAH1 CCDC13 AKAP4 CATSPER1 DST ALMS1 SMC3 MACF1 RPGR TRAK2 DIAPH3 DNAH5 DYNC1H1 CFAP46 | 1.62e-05 | 1058 | 145 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium movement | DNAH3 ANXA5 IFT81 DNAH2 DNAH1 AKAP4 CATSPER1 DNAH5 DYNC1H1 CFAP46 | 1.63e-05 | 261 | 145 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.82e-05 | 210 | 145 | 9 | GO:0060294 | |
| GeneOntologyBiologicalProcess | clathrin coat disassembly | 1.86e-05 | 8 | 145 | 3 | GO:0072318 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 2.19e-05 | 215 | 145 | 9 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 2.19e-05 | 215 | 145 | 9 | GO:0001539 | |
| GeneOntologyBiologicalProcess | vesicle uncoating | 2.77e-05 | 9 | 145 | 3 | GO:0072319 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNAH3 ANXA5 IFT81 DNAH2 DNAH1 AKAP4 CATSPER1 DST RPGR TRAK2 DNAH5 DYNC1H1 CFAP46 | 4.66e-05 | 493 | 145 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | EPS8 MYH6 MYH7 SPTA1 SH3GL2 MYO18A OBSL1 APOA1 NEB BCR ALMS1 TLN1 PAK2 LIMCH1 DIAPH3 MYO18B EPHA5 | 5.07e-05 | 803 | 145 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 6.33e-05 | 141 | 145 | 7 | GO:0001952 | |
| GeneOntologyBiologicalProcess | cilium assembly | CEP162 IFT81 DZIP1L DNAH2 DNAH1 CCDC13 AKAP4 ALMS1 CEP83 RPGR DNAH5 CFAP46 | 7.30e-05 | 444 | 145 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 1.16e-04 | 108 | 145 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor signaling pathway | 1.25e-04 | 69 | 145 | 5 | GO:0048010 | |
| GeneOntologyBiologicalProcess | cilium organization | CEP162 IFT81 DZIP1L DNAH2 DNAH1 CCDC13 AKAP4 ALMS1 CEP83 RPGR DNAH5 CFAP46 | 1.40e-04 | 476 | 145 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.63e-04 | 115 | 145 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.80e-04 | 127 | 145 | 6 | GO:0070252 | |
| GeneOntologyCellularComponent | myosin II complex | 1.44e-11 | 28 | 148 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin filament | 3.34e-10 | 25 | 148 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin complex | 8.53e-09 | 59 | 148 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH6 MYH7 MYH8 ANK1 ANXA5 OBSL1 NEB AKAP4 DST DMD MYO18B | 2.61e-08 | 249 | 148 | 13 | GO:0030017 |
| GeneOntologyCellularComponent | muscle myosin complex | 6.82e-08 | 16 | 148 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH6 MYH7 MYH8 ANK1 ANXA5 OBSL1 NEB AKAP4 DST DMD MYO18B | 7.68e-08 | 273 | 148 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | Z disc | 1.25e-07 | 151 | 148 | 10 | GO:0030018 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH6 MYH7 MYH8 AXL SPTA1 SH3GL1 MYO18A ANKRD26 IFIT5 NEB DST MACF1 LIMCH1 DIAPH3 MYO18B ACTRT1 | 1.43e-07 | 576 | 148 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH6 MYH7 MYH8 ANK1 ANXA5 OBSL1 NEB AKAP4 DST DMD MYO18B | 1.55e-07 | 290 | 148 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | I band | 3.02e-07 | 166 | 148 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 DNAH3 MYH6 MYH7 MYH8 DCDC1 ANK1 CEP162 ANXA5 NUMA1 DNAH2 MYO18A OBSL1 NEB DNAH1 AKAP4 DST MACF1 DIAPH3 DMD MYO18B DNAH5 DYNC1H1 | 2.78e-06 | 1179 | 148 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 DNAH3 MYH6 MYH7 MYH8 DCDC1 ANK1 CEP162 ANXA5 NUMA1 DNAH2 MYO18A OBSL1 NEB DNAH1 AKAP4 DST MACF1 DIAPH3 DMD MYO18B DNAH5 DYNC1H1 | 3.13e-06 | 1187 | 148 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.72e-05 | 25 | 148 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | A band | 3.30e-05 | 52 | 148 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | dynein complex | 3.98e-05 | 54 | 148 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.02e-05 | 10 | 148 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.14e-05 | 238 | 148 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNAH3 CEP162 DZIP1L NUMA1 DNAH2 DNAH1 DST TRAK2 DNAH5 DYNC1H1 CFAP46 | 5.30e-05 | 360 | 148 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNAH3 CEP162 DZIP1L DNAH2 DNAH1 DST TRAK2 DNAH5 DYNC1H1 CFAP46 | 8.98e-05 | 317 | 148 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule organizing center | LEO1 CETN2 CEP162 IFT81 DZIP1L NUMA1 MYO18A OBSL1 ANKRD26 CCDC13 ALMS1 CEP83 MASTL RPGR DIAPH3 PLEKHA7 TOP2A DYNC1H1 | 9.03e-05 | 919 | 148 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | ruffle membrane | 1.20e-04 | 108 | 148 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | centriole | 2.28e-04 | 172 | 148 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | cell cortex | 3.20e-04 | 371 | 148 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | axoneme | 6.95e-04 | 207 | 148 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.15e-04 | 208 | 148 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 7.33e-04 | 6 | 148 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | leading edge membrane | 7.56e-04 | 210 | 148 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 8.37e-04 | 155 | 148 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | motile cilium | 9.84e-04 | 355 | 148 | 9 | GO:0031514 | |
| GeneOntologyCellularComponent | centrosome | LEO1 CETN2 CEP162 IFT81 NUMA1 OBSL1 ANKRD26 CCDC13 ALMS1 CEP83 MASTL RPGR PLEKHA7 DYNC1H1 | 1.16e-03 | 770 | 148 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | intercalated disc | 1.38e-03 | 68 | 148 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | actomyosin | 1.47e-03 | 117 | 148 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.53e-03 | 118 | 148 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.73e-03 | 9 | 148 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | cilium | DNAH3 CETN2 CEP162 IFT81 DZIP1L DNAH2 DNAH1 AKAP4 CATSPER1 IFTAP ALMS1 CEP83 RPGR DNAH5 CFAP46 | 1.80e-03 | 898 | 148 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | basal dendrite | 2.16e-03 | 10 | 148 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | cell division site | 2.51e-03 | 80 | 148 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | ruffle | 3.52e-03 | 206 | 148 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | sperm principal piece | 3.72e-03 | 44 | 148 | 3 | GO:0097228 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 HYOU1 ANXA5 SH3GL1 OBSL1 ITK DST TLN1 PAK2 KDR DMD PLEKHA7 HSPA9 EPHA5 | 3.95e-03 | 976 | 148 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | sperm flagellum | 4.24e-03 | 214 | 148 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.49e-03 | 94 | 148 | 4 | GO:0044291 | |
| MousePheno | impaired skeletal muscle contractility | 1.65e-06 | 44 | 117 | 6 | MP:0002841 | |
| Domain | Myosin-like_IQ_dom | 6.21e-11 | 19 | 143 | 7 | IPR027401 | |
| Domain | - | 6.21e-11 | 19 | 143 | 7 | 4.10.270.10 | |
| Domain | Myosin_tail_1 | 3.12e-09 | 18 | 143 | 6 | PF01576 | |
| Domain | Myosin_tail | 3.12e-09 | 18 | 143 | 6 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 1.38e-08 | 38 | 143 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.38e-08 | 38 | 143 | 7 | PS51456 | |
| Domain | Myosin_head | 1.38e-08 | 38 | 143 | 7 | PF00063 | |
| Domain | MYSc | 1.38e-08 | 38 | 143 | 7 | SM00242 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.65e-08 | 14 | 143 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.65e-08 | 14 | 143 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.65e-08 | 14 | 143 | 5 | IPR013602 | |
| Domain | DHC_N2 | 4.65e-08 | 14 | 143 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.65e-08 | 14 | 143 | 5 | IPR011704 | |
| Domain | MT | 4.65e-08 | 14 | 143 | 5 | PF12777 | |
| Domain | AAA_8 | 4.65e-08 | 14 | 143 | 5 | PF12780 | |
| Domain | AAA_5 | 4.65e-08 | 14 | 143 | 5 | PF07728 | |
| Domain | DHC_fam | 6.93e-08 | 15 | 143 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 6.93e-08 | 15 | 143 | 5 | PF03028 | |
| Domain | Spectrin_alpha_SH3 | 6.93e-08 | 15 | 143 | 5 | IPR013315 | |
| Domain | Myosin_N | 6.93e-08 | 15 | 143 | 5 | PF02736 | |
| Domain | Dynein_heavy_dom | 6.93e-08 | 15 | 143 | 5 | IPR004273 | |
| Domain | Myosin_N | 6.93e-08 | 15 | 143 | 5 | IPR004009 | |
| Domain | Spectrin | 7.39e-07 | 23 | 143 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 2.51e-06 | 29 | 143 | 5 | IPR002017 | |
| Domain | IQ | 2.88e-06 | 81 | 143 | 7 | SM00015 | |
| Domain | SPEC | 4.18e-06 | 32 | 143 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.18e-06 | 32 | 143 | 5 | IPR018159 | |
| Domain | IQ_motif_EF-hand-BS | 5.85e-06 | 90 | 143 | 7 | IPR000048 | |
| Domain | IQ | 7.28e-06 | 93 | 143 | 7 | PS50096 | |
| Domain | IQ | 1.72e-05 | 71 | 143 | 6 | PF00612 | |
| Domain | DHC_N1 | 2.39e-05 | 8 | 143 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.39e-05 | 8 | 143 | 3 | IPR013594 | |
| Domain | SH3_1 | 3.88e-05 | 164 | 143 | 8 | PF00018 | |
| Domain | SH3 | 4.38e-05 | 216 | 143 | 9 | PS50002 | |
| Domain | SH3_domain | 5.05e-05 | 220 | 143 | 9 | IPR001452 | |
| Domain | TMEM191C | 5.82e-05 | 2 | 143 | 2 | PF15194 | |
| Domain | TMEM191B/C | 5.82e-05 | 2 | 143 | 2 | IPR028186 | |
| Domain | Tyr_kinase_cat_dom | 5.87e-05 | 88 | 143 | 6 | IPR020635 | |
| Domain | TyrKc | 5.87e-05 | 88 | 143 | 6 | SM00219 | |
| Domain | Kinase-like_dom | AXL ITK JAK3 BMX MAPK14 DST DCLK3 MASTL PAK2 MACF1 KDR DMD MAPK13 EPHA5 | 7.32e-05 | 542 | 143 | 14 | IPR011009 |
| Domain | P-loop_NTPase | MYH1 MYH2 NDST1 DNAH3 MYH6 MYH7 MYH8 DNAH2 MYO18A DDX1 DNAH1 SMC3 SMARCA1 ASCC3 MYO18B DNAH5 DYNC1H1 RAD17 | 8.59e-05 | 848 | 143 | 18 | IPR027417 |
| Domain | - | 9.19e-05 | 12 | 143 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 9.19e-05 | 12 | 143 | 3 | IPR029047 | |
| Domain | PROTEIN_KINASE_TYR | 1.01e-04 | 97 | 143 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.01e-04 | 97 | 143 | 6 | IPR008266 | |
| Domain | - | 1.19e-04 | 13 | 143 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.19e-04 | 13 | 143 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.19e-04 | 13 | 143 | 3 | IPR029048 | |
| Domain | CH | 1.40e-04 | 65 | 143 | 5 | SM00033 | |
| Domain | HnRNPA1 | 1.74e-04 | 3 | 143 | 2 | IPR021662 | |
| Domain | HnRNPA1 | 1.74e-04 | 3 | 143 | 2 | PF11627 | |
| Domain | BAR | 1.87e-04 | 15 | 143 | 3 | SM00721 | |
| Domain | BAR | 1.87e-04 | 15 | 143 | 3 | PF03114 | |
| Domain | CH | 1.99e-04 | 70 | 143 | 5 | PF00307 | |
| Domain | - | 2.13e-04 | 71 | 143 | 5 | 1.10.418.10 | |
| Domain | BAR_dom | 2.29e-04 | 16 | 143 | 3 | IPR004148 | |
| Domain | HSP70 | 2.29e-04 | 16 | 143 | 3 | PF00012 | |
| Domain | CH | 2.43e-04 | 73 | 143 | 5 | PS50021 | |
| Domain | CH-domain | 2.75e-04 | 75 | 143 | 5 | IPR001715 | |
| Domain | HSP70_2 | 2.76e-04 | 17 | 143 | 3 | PS00329 | |
| Domain | HSP70_1 | 2.76e-04 | 17 | 143 | 3 | PS00297 | |
| Domain | HSP70_3 | 2.76e-04 | 17 | 143 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 3.30e-04 | 18 | 143 | 3 | IPR013126 | |
| Domain | MAPK_p38 | 3.46e-04 | 4 | 143 | 2 | IPR008352 | |
| Domain | BAR | 3.89e-04 | 19 | 143 | 3 | PS51021 | |
| Domain | Pkinase_Tyr | 4.77e-04 | 129 | 143 | 6 | PF07714 | |
| Domain | - | 5.28e-04 | 21 | 143 | 3 | 1.10.720.30 | |
| Domain | SAP | 6.08e-04 | 22 | 143 | 3 | PF02037 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.81e-04 | 138 | 143 | 6 | IPR001245 | |
| Domain | Protein_kinase_ATP_BS | 6.88e-04 | 379 | 143 | 10 | IPR017441 | |
| Domain | SAP | 6.96e-04 | 23 | 143 | 3 | SM00513 | |
| Domain | ACTININ_2 | 6.96e-04 | 23 | 143 | 3 | PS00020 | |
| Domain | ACTININ_1 | 6.96e-04 | 23 | 143 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.96e-04 | 23 | 143 | 3 | IPR001589 | |
| Domain | PROTEIN_KINASE_ATP | 8.25e-04 | 459 | 143 | 11 | PS00107 | |
| Domain | AAA | 8.51e-04 | 144 | 143 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 8.51e-04 | 144 | 143 | 6 | IPR003593 | |
| Domain | - | 8.56e-04 | 6 | 143 | 2 | 3.90.1290.10 | |
| Domain | GAR | 8.56e-04 | 6 | 143 | 2 | PS51460 | |
| Domain | GAS2 | 8.56e-04 | 6 | 143 | 2 | PF02187 | |
| Domain | - | 8.56e-04 | 6 | 143 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 8.56e-04 | 6 | 143 | 2 | IPR003108 | |
| Domain | GAS2 | 8.56e-04 | 6 | 143 | 2 | SM00243 | |
| Domain | SAP | 8.93e-04 | 25 | 143 | 3 | PS50800 | |
| Domain | SAP_dom | 8.93e-04 | 25 | 143 | 3 | IPR003034 | |
| Domain | Plectin | 1.19e-03 | 7 | 143 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.19e-03 | 7 | 143 | 2 | IPR001101 | |
| Domain | PLEC | 1.19e-03 | 7 | 143 | 2 | SM00250 | |
| Domain | Prot_kinase_dom | 1.37e-03 | 489 | 143 | 11 | IPR000719 | |
| Domain | SH3 | 1.39e-03 | 216 | 143 | 7 | SM00326 | |
| Domain | PROTEIN_KINASE_DOM | 1.47e-03 | 493 | 143 | 11 | PS50011 | |
| Domain | AH/BAR-dom | 1.53e-03 | 30 | 143 | 3 | IPR027267 | |
| Domain | - | 1.53e-03 | 30 | 143 | 3 | 1.20.1270.60 | |
| Domain | PH_dom-like | 1.66e-03 | 426 | 143 | 10 | IPR011993 | |
| Domain | BTK | 2.02e-03 | 9 | 143 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 2.02e-03 | 9 | 143 | 2 | IPR001562 | |
| Domain | BTK | 2.02e-03 | 9 | 143 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.02e-03 | 9 | 143 | 2 | PS51113 | |
| Domain | MAPK | 3.65e-03 | 12 | 143 | 2 | PS01351 | |
| Domain | MAP_kinase_CS | 3.65e-03 | 12 | 143 | 2 | IPR003527 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.91e-05 | 70 | 112 | 6 | M12294 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.75e-05 | 27 | 112 | 4 | M47755 | |
| Pathway | KEGG_SPLICEOSOME | 6.75e-05 | 127 | 112 | 7 | M2044 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 1.01e-04 | 31 | 112 | 4 | MM14705 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 1.01e-04 | 31 | 112 | 4 | M16597 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | GIPC1 AXL SH3GL1 SH3GL2 SH3GL3 HNRNPA1L2 HNRNPA1 MAPK14 PAK2 KDR MAPK13 EPN1 | 1.20e-04 | 418 | 112 | 12 | MM15587 |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.63e-04 | 35 | 112 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.83e-04 | 36 | 112 | 4 | M18647 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 2.07e-04 | 15 | 112 | 3 | M27774 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 2.26e-04 | 38 | 112 | 4 | M39549 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | GIPC1 AXL SH3GL1 SH3GL2 SH3GL3 LAMC2 HNRNPA1 JAK3 MAPK14 PAK2 KDR MAPK13 EPN1 | 3.03e-04 | 532 | 112 | 13 | M27870 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.43e-04 | 165 | 112 | 7 | MM15026 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.67e-04 | 43 | 112 | 4 | M47669 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 4.31e-04 | 19 | 112 | 3 | M22005 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 4.38e-04 | 45 | 112 | 4 | M47670 | |
| Pathway | REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS | 5.04e-04 | 20 | 112 | 3 | M27780 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 5.85e-04 | 21 | 112 | 3 | MM15347 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 5.85e-04 | 21 | 112 | 3 | M27645 | |
| Pathway | KEGG_ENDOCYTOSIS | 5.98e-04 | 181 | 112 | 7 | M1519 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 6.07e-04 | 49 | 112 | 4 | MM14695 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 7.70e-04 | 23 | 112 | 3 | M39709 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 8.19e-04 | 53 | 112 | 4 | M27039 | |
| Pubmed | MYH1 MYH2 MYH6 MYH7 MYH8 DENND4A HYOU1 LEO1 KDM5A MRPL47 CES1 CETN2 SPTA1 IFT81 DZIP1L NUMA1 DNAH2 MYO18A ANKRD26 IFIT5 HNRNPA1L2 SRBD1 NEB HNRNPA1 DDX1 CDCA2 LIG4 SAFB DST SACS NAA20 CEP83 SMARCA1 ACIN1 MACF1 KDR LIMCH1 DIAPH3 DMD HSPA1L HSPA9 TOP2A CFAP46 | 2.07e-24 | 1442 | 150 | 43 | 35575683 | |
| Pubmed | MYH1 MYH7 HYOU1 LEO1 ANXA5 SH3GL1 NUMA1 HSP90AA5P DDX1 DST RPRD1A SMC3 TLN1 MACF1 DMD MYO18B SF3B2 HSPA9 TOP2A DYNC1H1 | 2.45e-13 | 538 | 150 | 20 | 28524877 | |
| Pubmed | 2.91e-11 | 7 | 150 | 5 | 16819597 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A HYOU1 ANXA5 NUMA1 HNRNPA1 CBS DDX1 CDCA2 TXLNA RBM25 SAFB RPRD1A SMC3 TLN1 SMARCA1 DNAJC9 ACIN1 UTP20 SCFD1 MYO18B PLEKHA7 DNAH5 SF3B2 HSPA9 TOP2A DYNC1H1 | 4.77e-10 | 1425 | 150 | 26 | 30948266 |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.66e-09 | 5 | 150 | 4 | 12919077 | |
| Pubmed | SRSF4 ANK1 NUMA1 IFIT5 LAMC2 TXLNA DST SACS TLN1 MACF1 DNAH5 TOP2A DYNC1H1 | 2.45e-09 | 332 | 150 | 13 | 37433992 | |
| Pubmed | 2.71e-09 | 14 | 150 | 5 | 9373155 | ||
| Pubmed | 2.71e-09 | 14 | 150 | 5 | 28153048 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | HYOU1 SRSF4 NUMA1 HNRNPA1 TXLNA RBM25 DST SMC3 TLN1 ACIN1 LIMCH1 HSPA1L SF3B2 HSPA9 DYNC1H1 | 2.75e-09 | 477 | 150 | 15 | 31300519 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HYOU1 ANXA5 NUMA1 OBSL1 HNRNPA1 DDX1 RBM25 SAFB DST SACS SMC3 TLN1 ACIN1 MACF1 UTP20 ASCC3 HEATR5B SF3B2 HSPA9 TOP2A DYNC1H1 | 3.57e-09 | 1024 | 150 | 21 | 24711643 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STXBP4 SH3GL1 NUMA1 ANKRD26 HNRNPA1 CBS SPC24 IBTK SAFB DST YKT6 ALMS1 TLN1 MASTL PAK2 ACIN1 MACF1 SF3B2 HSPA9 TOP2A | 4.22e-09 | 934 | 150 | 20 | 33916271 |
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 4.95e-09 | 6 | 150 | 4 | 10588881 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GIPC1 MYH7 HYOU1 SRSF4 CETN2 ANXA5 SH3GL1 MYO18A HNRNPA1 DDX1 DST SMC3 TLN1 DNAJC9 MACF1 LIMCH1 SCFD1 ASCC3 HSPA1L SF3B2 HSPA9 DYNC1H1 | 5.08e-09 | 1149 | 150 | 22 | 35446349 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EPS8 HYOU1 LRCH2 CEP162 STXBP4 IFT81 SH3GL1 SH3GL2 ANKRD26 BCR SPC24 IBTK TXLNA ALMS1 TLN1 PLEKHA7 HSPA9 TOP2A DYNC1H1 | 5.66e-09 | 853 | 150 | 19 | 28718761 |
| Pubmed | 6.62e-09 | 234 | 150 | 11 | 36243803 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 9256245 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 35210422 | ||
| Pubmed | 1.24e-08 | 142 | 150 | 9 | 30809309 | ||
| Pubmed | HYOU1 NUMA1 ANKRD26 IFIT5 HNRNPA1 EFR3A RBM25 DST SMC3 TLN1 PAK2 MACF1 DIAPH3 ASCC3 SF3B2 HSPA9 DYNC1H1 | 1.28e-08 | 708 | 150 | 17 | 39231216 | |
| Pubmed | HYOU1 CENPB CETN2 ANXA5 MYO18A LAMC2 APOA1 GPD1L DST TLN1 DNAJC9 ACIN1 MACF1 ZMYM1 PLEKHA7 TOP2A | 1.77e-08 | 634 | 150 | 16 | 34591612 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HYOU1 KDM5A CETN2 SH3GL1 MYO18A ANKRD26 BCR HNRNPA1 POLR1D IBTK TXLNA TLN1 PAK2 MACF1 ZMYM1 DIAPH3 ASCC3 | 1.77e-08 | 724 | 150 | 17 | 36232890 |
| Pubmed | 2.05e-08 | 20 | 150 | 5 | 21689717 | ||
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 3864153 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | LYRM7 DNAH3 LEO1 NUMA1 DNAH2 HNRNPA1L2 HSP90AA5P HNRNPA1 DDX1 TXLNA RBM25 SMC3 TLN1 MACF1 HSPA1L SF3B2 HSPA9 DYNC1H1 | 3.00e-08 | 847 | 150 | 18 | 35235311 |
| Pubmed | GIPC1 EPS8 SRSF4 NUMA1 MYO18A HNRNPA1 DDX1 EFR3A RBM25 SAFB DST SMC3 SMARCA1 ACIN1 MACF1 TOP2A | 3.09e-08 | 660 | 150 | 16 | 32780723 | |
| Pubmed | 3.46e-08 | 22 | 150 | 5 | 24301466 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 31960486 | ||
| Pubmed | EPS8 MYH6 HYOU1 LRCH2 SPTA1 SH3GL1 MYO18A HNRNPA1L2 BCR HNRNPA1 DDX1 GPD1L SAFB DST TTC7B SACS TLN1 MACF1 LIMCH1 DMD PLEKHA7 HSPA9 DYNC1H1 | 5.55e-08 | 1431 | 150 | 23 | 37142655 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 21470888 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 7.86e-08 | 3 | 150 | 3 | 1371481 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HYOU1 SRSF4 SH3GL2 NUMA1 HNRNPA1L2 NUDT13 HNRNPA1 DDX1 SAFB SMC3 DNAJC9 HSPA1L SF3B2 HSPA9 TOP2A DYNC1H1 | 9.04e-08 | 714 | 150 | 16 | 28302793 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ANXA5 NUMA1 SRBD1 HNRNPA1 DDX1 CDCA2 POLR1D SAFB DST SMC3 TLN1 SMARCA1 ACIN1 MACF1 UTP20 SCFD1 ASCC3 HSPA1L SF3B2 HSPA9 TOP2A DYNC1H1 | 9.14e-08 | 1353 | 150 | 22 | 29467282 |
| Pubmed | GIPC1 SRSF4 LRCH2 MRPL47 ANXA5 SH3GL1 SH3GL2 NUMA1 BCR CBS RBM25 RPRD1A SMC3 TLN1 DNAJC9 PAK2 DMD PLEKHA7 | 9.67e-08 | 916 | 150 | 18 | 32203420 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HYOU1 NUMA1 MYO18A LAMC2 SRBD1 HNRNPA1 DDX1 TXLNA RBM25 SAFB DST SMC3 SMARCA1 DNAJC9 ACIN1 UTP20 ASCC3 SF3B2 HSPA9 TOP2A DYNC1H1 | 1.18e-07 | 1257 | 150 | 21 | 36526897 |
| Pubmed | 1.34e-07 | 187 | 150 | 9 | 26460568 | ||
| Pubmed | LRCH2 NUMA1 BCR HNRNPA1 POLR3G POLR1D TAF3 SAFB YKT6 HSPA1L SF3B2 HSPA9 | 1.44e-07 | 390 | 150 | 12 | 17643375 | |
| Pubmed | MYH1 MYH2 MYH6 MYH8 HNRNPA1L2 NEB HNRNPA1 DDX1 DST TLN1 MACF1 SCFD1 DMD HSPA1L HSPA9 TOP2A DYNC1H1 | 1.59e-07 | 844 | 150 | 17 | 25963833 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NUMA1 MYO18A OBSL1 HNRNPA1L2 HSP90AA5P HNRNPA1 DDX1 RBM25 SAFB DST SMC3 DNAJC9 UTP20 LIMCH1 SF3B2 HSPA9 TOP2A DYNC1H1 | 1.63e-07 | 949 | 150 | 18 | 36574265 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.31e-07 | 13 | 150 | 4 | 8404542 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP DENND4A LRCH2 LEO1 CENPB ANXA5 IFT81 OBSL1 BCR CBS DDX1 POSTN TXLNA RPRD1A SMC3 DNAJC9 POLL RPGR PLEKHA7 HSPA1L DYNC1H1 | 2.68e-07 | 1321 | 150 | 21 | 27173435 |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 9122235 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 20357587 | ||
| Pubmed | Endophilin-A coordinates priming and fusion of neurosecretory vesicles via intersectin. | 3.14e-07 | 4 | 150 | 3 | 32152276 | |
| Pubmed | LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. | 3.14e-07 | 4 | 150 | 3 | 22998870 | |
| Pubmed | Synaptojanin and Endophilin Mediate Neck Formation during Ultrafast Endocytosis. | 3.14e-07 | 4 | 150 | 3 | 29953872 | |
| Pubmed | Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations. | 3.14e-07 | 4 | 150 | 3 | 18761673 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 8954775 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 10816441 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | NUMA1 HNRNPA1L2 HNRNPA1 DDX1 RBM25 SMARCA1 ACIN1 SF3B2 HSPA9 TOP2A | 3.14e-07 | 271 | 150 | 10 | 32433965 |
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 27184118 | ||
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 24938781 | ||
| Pubmed | 3.43e-07 | 209 | 150 | 9 | 36779422 | ||
| Pubmed | SRSF4 MYO18A HNRNPA1 DDX1 SAFB SMC3 ACIN1 PLEKHA7 SF3B2 HSPA9 | 3.47e-07 | 274 | 150 | 10 | 34244482 | |
| Pubmed | 3.90e-07 | 65 | 150 | 6 | 32521226 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | LEO1 NUMA1 HNRNPA1 DDX1 RBM25 SAFB SMC3 SMARCA1 ACIN1 ASCC3 HSPA1L SF3B2 HSPA9 TOP2A | 4.10e-07 | 605 | 150 | 14 | 28977666 |
| Pubmed | GIPC1 MED20 LEO1 CENPB CETN2 ANXA5 ANXA7 NUMA1 DDX1 TAF3 RBM25 SAFB SMC3 DNAJC9 PAK2 ACIN1 SF3B2 TOP2A | 4.28e-07 | 1014 | 150 | 18 | 32416067 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH6 MYH7 MYH8 LEO1 AXL CCDC186 OBSL1 BCR ITK TXLNA MAPK14 DST TLN1 MAPK13 HSPA9 | 4.55e-07 | 910 | 150 | 17 | 36736316 |
| Pubmed | HYOU1 MRPL47 STXBP4 IFT81 MYO18A OBSL1 ANKRD26 HNRNPA1 EFR3A TXLNA SYNE3 YKT6 SACS TLN1 DNAJC9 MACF1 SCFD1 DIAPH3 ASCC3 HSPA1L SF3B2 HSPA9 | 4.56e-07 | 1487 | 150 | 22 | 33957083 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRSF4 ANXA7 MYO18A IFIT5 HNRNPA1 DDX1 RBM25 SAFB ACIN1 MACF1 UTP20 ASCC3 SF3B2 HSPA9 TOP2A DYNC1H1 | 4.65e-07 | 807 | 150 | 16 | 22681889 |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 5.81e-07 | 16 | 150 | 4 | 19922871 | |
| Pubmed | SRSF4 LEO1 KDM5A MRPL47 IFIT5 HNRNPA1L2 HSP90AA5P HNRNPA1 DDX1 NSUN3 SMC3 DNAJC9 MACF1 SCFD1 HEATR5B HSPA1L SF3B2 HSPA9 DYNC1H1 | 6.13e-07 | 1153 | 150 | 19 | 29845934 | |
| Pubmed | 7.14e-07 | 39 | 150 | 5 | 38690566 | ||
| Pubmed | GIPC1 NDST1 LEO1 KDM5A IFT81 ANXA7 OBSL1 IFIT5 DNAAF9 CBS CCDC13 DST RPRD1A TTC7B SACS PAK2 MACF1 SF3B2 HSPA9 DYNC1H1 | 7.36e-07 | 1285 | 150 | 20 | 35914814 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 25471590 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 7.81e-07 | 5 | 150 | 3 | 3829126 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 12034747 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 6196357 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 27720640 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 7.81e-07 | 5 | 150 | 3 | 17584907 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 8.06e-07 | 170 | 150 | 8 | 16159877 | |
| Pubmed | 8.94e-07 | 304 | 150 | 10 | 32235678 | ||
| Pubmed | DENND4A HYOU1 LEO1 OBSL1 LAMC2 BCR DDX1 LIG4 IBTK TXLNA DST EPN1 SF3B2 SEMA3E | 9.60e-07 | 650 | 150 | 14 | 38777146 | |
| Pubmed | 1.05e-06 | 239 | 150 | 9 | 26641092 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRSF4 LRCH2 KDM5A ANXA5 ANXA7 MYO18A HNRNPA1 DDX1 POLR1D TAF3 RBM25 SAFB DST SACS ACIN1 MACF1 SF3B2 DYNC1H1 | 1.08e-06 | 1082 | 150 | 18 | 38697112 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A KDM5A CEP162 STXBP4 SH3GL1 ANKRD26 BCR DDX1 ITK CDCA2 BMX DST ALMS1 MACF1 LIMCH1 PLEKHA7 | 1.08e-06 | 861 | 150 | 16 | 36931259 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HYOU1 SRSF4 ANK1 KDM5A NUMA1 HNRNPA1 DDX1 POLR1D TAF3 RBM25 SAFB SMC3 PAK2 ACIN1 SCFD1 ASCC3 SF3B2 HSPA9 TOP2A DYNC1H1 | 1.09e-06 | 1318 | 150 | 20 | 30463901 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPB NUMA1 MYO18A SRBD1 DDX1 CDCA2 IBTK TXLNA SMC3 DNAJC9 ACIN1 MACF1 UTP20 ASCC3 TOP2A | 1.13e-06 | 759 | 150 | 15 | 35915203 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.30e-06 | 317 | 150 | 10 | 17620599 | |
| Pubmed | HYOU1 SRSF4 SH3GL1 HNRNPA1L2 BCR HSP90AA5P HNRNPA1 CBS DDX1 MAPK14 RPRD1A SMC3 WDR87 SMARCA1 DNAJC9 SCFD1 ASCC3 HSPA1L SF3B2 HSPA9 | 1.32e-06 | 1335 | 150 | 20 | 29229926 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CETN2 ANXA7 SH3GL1 NUMA1 SRBD1 HNRNPA1 DDX1 CDCA2 RBM25 SAFB SMC3 DNAJC9 ACIN1 UTP20 SF3B2 HSPA9 TOP2A | 1.42e-06 | 989 | 150 | 17 | 36424410 |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 31202577 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 10764144 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.56e-06 | 6 | 150 | 3 | 10077619 | |
| Pubmed | Binding properties of SH3 peptide ligands identified from phage-displayed random peptide libraries. | 1.56e-06 | 6 | 150 | 3 | 9238627 | |
| Pubmed | Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. | 1.56e-06 | 6 | 150 | 3 | 23187129 | |
| Pubmed | A novel SH3-containing human gene family preferentially expressed in the central nervous system. | 1.56e-06 | 6 | 150 | 3 | 9169142 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.64e-06 | 130 | 150 | 7 | 35545047 | |
| Pubmed | 1.67e-06 | 83 | 150 | 6 | 11114734 | ||
| Pubmed | HYOU1 ANXA5 ANXA7 NUMA1 MYO18A HNRNPA1L2 HNRNPA1 DDX1 SAFB SMC3 TLN1 DNAJC9 ACIN1 TOP2A DYNC1H1 | 1.73e-06 | 786 | 150 | 15 | 29128334 | |
| Pubmed | MYH7 MYH8 DENND4A KDM5A ANKRD26 NEB DST ALMS1 TLN1 MACF1 MYO18B HSPA9 | 1.85e-06 | 497 | 150 | 12 | 23414517 | |
| Pubmed | 1.85e-06 | 47 | 150 | 5 | 8812413 | ||
| Pubmed | MED20 SRSF4 ANXA5 SH3GL1 NUMA1 HNRNPA1 DDX1 DNAH1 RBM25 SMC3 WDR87 TLN1 ACIN1 LIMCH1 ASCC3 SF3B2 HSPA9 TOP2A DYNC1H1 | 1.95e-06 | 1247 | 150 | 19 | 27684187 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NUMA1 HNRNPA1L2 DDX1 SAFB SMC3 TLN1 ACIN1 SF3B2 TOP2A DYNC1H1 | 1.97e-06 | 332 | 150 | 10 | 32786267 |
| Pubmed | MED20 KDM5A CETN2 ANXA5 NUMA1 OBSL1 APOA1 IBTK TXLNA TAF3 RBM25 TLN1 SMARCA1 DNAJC9 ACIN1 LIMCH1 ASCC3 SF3B2 HSPA9 DYNC1H1 | 1.98e-06 | 1371 | 150 | 20 | 36244648 | |
| Pubmed | EPS8 LRCH2 LEO1 NUMA1 LAMC2 DDX1 RBM25 DST TLN1 ACIN1 SF3B2 DYNC1H1 | 2.22e-06 | 506 | 150 | 12 | 30890647 | |
| Pubmed | SRSF4 NUMA1 MYO18A HNRNPA1 DDX1 SMARCA1 DNAJC9 MACF1 ASCC3 PLEKHA7 SF3B2 TOP2A DYNC1H1 | 2.28e-06 | 601 | 150 | 13 | 33658012 | |
| Pubmed | NUMA1 SRBD1 HNRNPA1 DDX1 RBM25 SMC3 DNAJC9 LIMCH1 SF3B2 TOP2A | 2.44e-06 | 340 | 150 | 10 | 24332808 | |
| Pubmed | SRSF4 LRCH2 MRPL47 HNRNPA1 CBS DDX1 TXLNA RBM25 SMC3 ACIN1 DMD ASCC3 SF3B2 HSPA9 DYNC1H1 | 2.46e-06 | 809 | 150 | 15 | 32129710 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 2.53e-06 | 50 | 150 | 5 | 27597886 | |
| Interaction | RSPH6A interactions | 1.48e-07 | 34 | 146 | 6 | int:RSPH6A | |
| Interaction | MCM2 interactions | MYH1 MYH2 MYH6 MYH8 HYOU1 NUMA1 OBSL1 HNRNPA1L2 NEB BCR HNRNPA1 DDX1 DNAH1 TAF3 DST SMC3 TLN1 DNAJC9 MACF1 SCFD1 DMD HSPA1L SF3B2 HSPA9 DYNC1H1 | 2.40e-07 | 1081 | 146 | 25 | int:MCM2 |
| Interaction | LINC01554 interactions | 9.46e-07 | 142 | 146 | 9 | int:LINC01554 | |
| Interaction | NAA40 interactions | CETN2 STXBP4 SH3GL1 NUMA1 ANKRD26 HNRNPA1 CBS SPC24 IBTK SAFB DST YKT6 ALMS1 TLN1 MASTL PAK2 ACIN1 MACF1 LIMCH1 SF3B2 HSPA9 TOP2A | 2.19e-06 | 978 | 146 | 22 | int:NAA40 |
| Interaction | H3C1 interactions | GIPC1 LEO1 KDM5A KMT5A NUMA1 DNAH2 MYO18A HNRNPA1L2 SRBD1 NEB HNRNPA1 DNAH1 CDCA2 TAF3 SMC3 WDR87 SMARCA1 DNAJC9 SF3B2 TOP2A DYNC1H1 | 2.20e-06 | 901 | 146 | 21 | int:H3C1 |
| Interaction | DNAH2 interactions | 4.38e-06 | 34 | 146 | 5 | int:DNAH2 | |
| Interaction | MEX3A interactions | SRSF4 ANK1 NUMA1 IFIT5 LAMC2 TXLNA DST SACS TLN1 MACF1 DNAH5 TOP2A DYNC1H1 | 4.60e-06 | 384 | 146 | 13 | int:MEX3A |
| Interaction | FBXO32 interactions | MYH1 MYH6 MYH8 SRSF4 SH3GL1 SH3GL2 SH3GL3 HNRNPA1 PAK2 UTP20 ASCC3 HSPA9 TOP2A | 4.87e-06 | 386 | 146 | 13 | int:FBXO32 |
| Interaction | MYH6 interactions | 5.48e-06 | 94 | 146 | 7 | int:MYH6 | |
| Interaction | ERCC6 interactions | LEO1 MRPL47 SPTA1 HNRNPA1L2 HNRNPA1 DDX1 SMARCA1 SF3B2 HSPA9 TOP2A | 5.58e-06 | 224 | 146 | 10 | int:ERCC6 |
| Interaction | TSPAN33 interactions | 7.58e-06 | 65 | 146 | 6 | int:TSPAN33 | |
| Interaction | OBSL1 interactions | NUMA1 OBSL1 HNRNPA1 DDX1 DNAH1 BMX RBM25 SAFB MAPK14 DST SMC3 TLN1 DNAJC9 ACIN1 MACF1 UTP20 SF3B2 HSPA9 TOP2A DYNC1H1 | 8.25e-06 | 902 | 146 | 20 | int:OBSL1 |
| Interaction | SRRM1 interactions | SRSF4 CETN2 NUMA1 OBSL1 RBM25 SAFB SMC3 DNAJC9 ACIN1 SF3B2 TOP2A DYNC1H1 | 9.03e-06 | 348 | 146 | 12 | int:SRRM1 |
| Interaction | RHOB interactions | DAB2IP GIPC1 EPS8 SH3GL1 MYO18A ANKRD26 BCR EFR3A YKT6 TTC7B PAK2 MACF1 UTP20 SCFD1 DIAPH3 EPN1 PLEKHA7 HSPA9 EPHA5 | 1.07e-05 | 840 | 146 | 19 | int:RHOB |
| Interaction | CUL7 interactions | HYOU1 ANXA5 NUMA1 OBSL1 APOA1 HNRNPA1 DDX1 RBM25 SAFB MAPK14 SMC3 TLN1 ACIN1 MACF1 HSPA1L SF3B2 HSPA9 TOP2A DYNC1H1 | 1.17e-05 | 845 | 146 | 19 | int:CUL7 |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH6 MYH7 MYH8 HYOU1 SRSF4 SH3GL3 ANKRD26 MAPK14 SYNE3 YKT6 DNAJC9 ACIN1 HSPA9 | 1.24e-05 | 554 | 146 | 15 | int:BCAP31 |
| Interaction | EED interactions | HYOU1 KDM5A KMT5A ANXA5 ANXA7 NUMA1 MYO18A HNRNPA1 DDX1 RBM25 SAFB YKT6 SMC3 TLN1 SMARCA1 PAK2 ACIN1 MACF1 UTP20 LIMCH1 SCFD1 ASCC3 EPN1 HSPA9 TOP2A DYNC1H1 | 1.40e-05 | 1445 | 146 | 26 | int:EED |
| Interaction | IFI16 interactions | SRSF4 CENPB NUMA1 HNRNPA1L2 SRBD1 HNRNPA1 DDX1 RBM25 SAFB SMARCA1 DNAJC9 ACIN1 UTP20 ASCC3 HEATR5B HSPA9 TOP2A | 1.69e-05 | 714 | 146 | 17 | int:IFI16 |
| Interaction | KCNA3 interactions | HYOU1 NUMA1 MYO18A ANKRD26 IFIT5 HNRNPA1 EFR3A RBM25 DST SMC3 TLN1 PAK2 MACF1 DIAPH3 ASCC3 DNAH5 SF3B2 HSPA9 DYNC1H1 | 1.78e-05 | 871 | 146 | 19 | int:KCNA3 |
| Interaction | PRKAR1A interactions | SH3GL3 OBSL1 ANKRD26 CBS JAK3 AKAP4 SAFB TLN1 PAK2 HSPA9 DYNC1H1 | 1.92e-05 | 315 | 146 | 11 | int:PRKAR1A |
| Interaction | CDK3 interactions | 1.95e-05 | 114 | 146 | 7 | int:CDK3 | |
| Interaction | GLDC interactions | SRSF4 MYO18A HNRNPA1 DDX1 SAFB SMC3 ACIN1 PLEKHA7 SF3B2 HSPA9 SEMA3E | 2.29e-05 | 321 | 146 | 11 | int:GLDC |
| Interaction | NINL interactions | CEP162 STXBP4 IFT81 ANKRD26 BCR DNAH1 TXLNA ALMS1 DIAPH3 PLEKHA7 HSPA1L TOP2A DYNC1H1 | 2.98e-05 | 458 | 146 | 13 | int:NINL |
| Interaction | LCK interactions | AXL OBSL1 ANKRD26 ITK EFR3A JAK3 BMX SAFB DST PAK2 MACF1 PLEKHA7 HSPA9 | 3.33e-05 | 463 | 146 | 13 | int:LCK |
| Interaction | PINK1 interactions | HYOU1 SRSF4 NUMA1 HSP90AA5P HNRNPA1 TXLNA RBM25 DST SMC3 TLN1 ACIN1 LIMCH1 HSPA1L SF3B2 HSPA9 DYNC1H1 | 3.44e-05 | 679 | 146 | 16 | int:PINK1 |
| Interaction | NUPR1 interactions | GIPC1 EPS8 SRSF4 NUMA1 MYO18A HNRNPA1 DDX1 EFR3A RBM25 SAFB DST SMC3 SMARCA1 ACIN1 MACF1 TOP2A | 3.69e-05 | 683 | 146 | 16 | int:NUPR1 |
| Interaction | PRR5-ARHGAP8 interactions | 4.31e-05 | 10 | 146 | 3 | int:PRR5-ARHGAP8 | |
| Interaction | FCMR interactions | 5.89e-05 | 11 | 146 | 3 | int:FCMR | |
| Interaction | CFTR interactions | MYH1 EPS8 MYH2 MYH6 MYH7 MYH8 HYOU1 AXL ANXA5 MYO18A LAMC2 NRIP3 BCR DDX1 RBM25 TLN1 MACF1 LIMCH1 DMD HSPA1L SF3B2 HSPA9 TOP2A DYNC1H1 SEMA3E | 5.93e-05 | 1480 | 146 | 25 | int:CFTR |
| Interaction | CEP128 interactions | CEP162 STXBP4 IFT81 ANKRD26 BCR IBTK TXLNA SYNE3 ALMS1 ASCC3 | 6.30e-05 | 297 | 146 | 10 | int:CEP128 |
| Interaction | TNIP1 interactions | NUMA1 MYO18A OBSL1 HNRNPA1L2 HSP90AA5P HNRNPA1 DDX1 TXLNA RBM25 SAFB SYNE3 DST SMC3 DNAJC9 UTP20 LIMCH1 SCFD1 DMD SF3B2 HSPA9 TOP2A DYNC1H1 | 6.53e-05 | 1217 | 146 | 22 | int:TNIP1 |
| Interaction | HSP90AB1 interactions | AXL NUMA1 DNAH2 OBSL1 NEB HSP90AA5P HNRNPA1 ITK JAK3 POLR1D TXLNA BMX MAPK14 TLN1 ACIN1 MAPK13 HSPA1L SF3B2 RAD17 | 6.65e-05 | 960 | 146 | 19 | int:HSP90AB1 |
| Interaction | BTF3 interactions | MYH2 MYH7 CETN2 NUMA1 MYO18A HNRNPA1 DDX1 TXLNA SAFB IFTAP DNAJC9 LIMCH1 ASCC3 HSPA1L HSPA9 TOP2A DYNC1H1 | 6.91e-05 | 799 | 146 | 17 | int:BTF3 |
| Interaction | TRAF3IP1 interactions | 7.07e-05 | 96 | 146 | 6 | int:TRAF3IP1 | |
| Interaction | NAA20 interactions | 7.14e-05 | 31 | 146 | 4 | int:NAA20 | |
| Interaction | PLEC interactions | DNAH3 SPTA1 MYO18A OBSL1 HNRNPA1 SYNE3 DST SMC3 MACF1 MYO18B DNAH5 FILIP1L | 7.16e-05 | 430 | 146 | 12 | int:PLEC |
| Interaction | NAT10 interactions | 7.24e-05 | 302 | 146 | 10 | int:NAT10 | |
| Interaction | VCL interactions | 7.86e-05 | 305 | 146 | 10 | int:VCL | |
| Interaction | CCDC8 interactions | MROH2A NUMA1 OBSL1 HNRNPA1 MAPK14 DST SACS SMC3 MACF1 UTP20 ASCC3 HEATR5B HSPA9 TOP2A DYNC1H1 | 8.58e-05 | 656 | 146 | 15 | int:CCDC8 |
| Interaction | PLK1 interactions | DAB2IP CEP162 STXBP4 BCR RBM25 SYNE3 IFTAP SACS SMC3 MASTL TRAK2 HSPA9 TOP2A | 8.90e-05 | 510 | 146 | 13 | int:PLK1 |
| Interaction | BIRC3 interactions | DENND4A HYOU1 ANXA5 NUMA1 HNRNPA1 CBS DDX1 CDCA2 TXLNA RBM25 SAFB RPRD1A SMC3 TLN1 DNAJC9 ACIN1 UTP20 PLEKHA7 DNAH5 SF3B2 HSPA9 TOP2A DYNC1H1 | 8.98e-05 | 1334 | 146 | 23 | int:BIRC3 |
| Interaction | POU5F1 interactions | LEO1 MRPL47 CETN2 SH3GL1 NUMA1 L1TD1 IBTK MAPK14 RPRD1A SMC3 ACIN1 HSPA9 TOP2A DYNC1H1 | 9.09e-05 | 584 | 146 | 14 | int:POU5F1 |
| Interaction | ABTB2 interactions | 9.39e-05 | 101 | 146 | 6 | int:ABTB2 | |
| Interaction | GAN interactions | 9.74e-05 | 253 | 146 | 9 | int:GAN | |
| Interaction | CBL interactions | EPS8 MYH2 AXL SPTA1 ANXA7 SH3GL2 SH3GL3 BCR ITK MAPK14 KDR HSPA1L HSPA9 | 1.00e-04 | 516 | 146 | 13 | int:CBL |
| Interaction | H2BC9 interactions | LYRM7 MYH2 USP45 LRCH2 NUMA1 NEB DNAH1 CDCA2 DST SMC3 DNAH5 TOP2A | 1.01e-04 | 446 | 146 | 12 | int:H2BC9 |
| Interaction | IQGAP1 interactions | MYH1 ANXA5 MYO18A OBSL1 HNRNPA1 BMX MAPK14 DST SMC3 ACIN1 KDR LIMCH1 ASCC3 DYNC1H1 | 1.03e-04 | 591 | 146 | 14 | int:IQGAP1 |
| Interaction | MED4 interactions | MED20 CEP162 IFT81 ANKRD26 IFIT5 SPC24 POLR1D TXLNA DST RPRD1A ALMS1 TLN1 | 1.10e-04 | 450 | 146 | 12 | int:MED4 |
| Interaction | KDR interactions | 1.12e-04 | 150 | 146 | 7 | int:KDR | |
| Interaction | PDCD6 interactions | 1.23e-04 | 204 | 146 | 8 | int:PDCD6 | |
| Interaction | DNAH6 interactions | 1.30e-04 | 36 | 146 | 4 | int:DNAH6 | |
| Interaction | PRKAG2 interactions | 1.35e-04 | 68 | 146 | 5 | int:PRKAG2 | |
| Interaction | FBXO28 interactions | 1.36e-04 | 108 | 146 | 6 | int:FBXO28 | |
| Interaction | GSK3A interactions | DENND4A LRCH2 SRBD1 BCR IBTK RBM25 DST ALMS1 ACIN1 MACF1 TRAK2 ASCC3 | 1.46e-04 | 464 | 146 | 12 | int:GSK3A |
| Interaction | ACTC1 interactions | EPS8 LRCH2 LEO1 NUMA1 OBSL1 LAMC2 DDX1 RBM25 DST IFTAP TLN1 ACIN1 DMD SF3B2 DYNC1H1 | 1.59e-04 | 694 | 146 | 15 | int:ACTC1 |
| Interaction | ZSCAN5A interactions | 1.61e-04 | 38 | 146 | 4 | int:ZSCAN5A | |
| Interaction | NUMA1 interactions | NUMA1 DNAH2 OBSL1 HNRNPA1L2 HNRNPA1 POLR3G SMC3 TLN1 SMARCA1 MACF1 TOP2A DYNC1H1 | 1.62e-04 | 469 | 146 | 12 | int:NUMA1 |
| Interaction | PRKDC interactions | AXL MYO18A OBSL1 HNRNPA1 JAK3 LIG4 RBM25 SMC3 ACIN1 POLL KDR SF3B2 TOP2A DYNC1H1 RAD17 | 1.62e-04 | 695 | 146 | 15 | int:PRKDC |
| Interaction | ZWINT interactions | 1.68e-04 | 160 | 146 | 7 | int:ZWINT | |
| Interaction | TERF2 interactions | 1.91e-04 | 340 | 146 | 10 | int:TERF2 | |
| Interaction | RBM39 interactions | HYOU1 SRSF4 SH3GL2 NUMA1 OBSL1 HNRNPA1L2 NUDT13 HNRNPA1 DDX1 RBM25 SAFB SMC3 DNAJC9 ACIN1 HSPA1L SF3B2 HSPA9 TOP2A DYNC1H1 | 1.93e-04 | 1042 | 146 | 19 | int:RBM39 |
| Interaction | EPX interactions | 1.95e-04 | 16 | 146 | 3 | int:EPX | |
| Interaction | BAP1 interactions | GIPC1 MYH7 HYOU1 SRSF4 CETN2 ANXA5 SH3GL1 MYO18A HNRNPA1 DDX1 DST SMC3 TLN1 DNAJC9 MACF1 LIMCH1 SCFD1 ASCC3 HSPA1L SF3B2 HSPA9 DYNC1H1 | 1.97e-04 | 1314 | 146 | 22 | int:BAP1 |
| Interaction | YWHAZ interactions | DAB2IP BDP1 DENND4A AXL CEP162 SPTA1 SH3GL1 MYO18A OBSL1 ANKRD26 NEB BCR HNRNPA1 TXLNA DST RPRD1A PAK2 MACF1 PLEKHA7 SF3B2 HSPA9 DYNC1H1 | 2.08e-04 | 1319 | 146 | 22 | int:YWHAZ |
| Interaction | OFD1 interactions | HYOU1 CEP162 STXBP4 IFT81 SPC24 TXLNA SYNE3 TRAK2 DIAPH3 DYNC1H1 | 2.25e-04 | 347 | 146 | 10 | int:OFD1 |
| Interaction | RET interactions | 2.32e-04 | 284 | 146 | 9 | int:RET | |
| Interaction | GCN1 interactions | 2.35e-04 | 349 | 146 | 10 | int:GCN1 | |
| Interaction | PRC1 interactions | BDP1 NUMA1 MYO18A LAMC2 HNRNPA1L2 HNRNPA1 DDX1 ITK RBM25 SAFB CEP83 SMARCA1 ACIN1 UTP20 SF3B2 TOP2A DYNC1H1 EPHA5 | 2.42e-04 | 973 | 146 | 18 | int:PRC1 |
| Interaction | GRB2 interactions | EPS8 HYOU1 AXL MYO18A BCR ITK POLR1D MAPK14 PAK2 KDR PLEKHA7 HSPA1L SF3B2 HSPA9 DYNC1H1 EPHA5 | 2.51e-04 | 806 | 146 | 16 | int:GRB2 |
| Interaction | FBF1 interactions | 2.53e-04 | 171 | 146 | 7 | int:FBF1 | |
| Interaction | AURKC interactions | 2.62e-04 | 43 | 146 | 4 | int:AURKC | |
| Interaction | FBXL13 interactions | 2.86e-04 | 44 | 146 | 4 | int:FBXL13 | |
| Interaction | HSP90AA1 interactions | MYH7 AXL NUMA1 APOA1 DNAAF9 BCR HSP90AA5P HNRNPA1 ITK JAK3 TXLNA BMX MAPK14 WDR87 TLN1 KDR ZMYM1 MAPK13 HSPA1L HSPA9 DYNC1H1 | 3.07e-04 | 1263 | 146 | 21 | int:HSP90AA1 |
| Interaction | CEP63 interactions | 3.33e-04 | 179 | 146 | 7 | int:CEP63 | |
| Interaction | PFN1 interactions | GIPC1 ANXA5 OBSL1 ANKRD26 BCR HNRNPA1 LIG4 ALMS1 MACF1 LIMCH1 DIAPH3 SF3B2 | 3.41e-04 | 509 | 146 | 12 | int:PFN1 |
| Interaction | SRC interactions | EPS8 AXL LSMEM1 ANXA7 HNRNPA1L2 BCR HNRNPA1 ITK BMX TLN1 SMARCA1 PAK2 KDR HSPA9 | 3.41e-04 | 664 | 146 | 14 | int:SRC |
| Interaction | STK3 interactions | 3.57e-04 | 181 | 146 | 7 | int:STK3 | |
| Interaction | PTPN11 interactions | 3.58e-04 | 368 | 146 | 10 | int:PTPN11 | |
| Interaction | MIR199A1 interactions | 3.63e-04 | 84 | 146 | 5 | int:MIR199A1 | |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH6 MYH7 MYH8 STXBP4 ANKRD26 NEB SYNE3 ALMS1 DNAJC9 | 3.70e-04 | 440 | 146 | 11 | int:LATS1 |
| Interaction | G3BP1 interactions | SRSF4 CENPB ANXA7 OBSL1 HNRNPA1 DDX1 IBTK SAFB DST RPRD1A SMARCA1 MACF1 ASCC3 HSPA9 TOP2A DYNC1H1 | 3.71e-04 | 835 | 146 | 16 | int:G3BP1 |
| Interaction | SUMO2 interactions | ANXA5 NUMA1 HNRNPA1L2 DDX1 SAFB DST SMC3 TLN1 ACIN1 SF3B2 HSPA9 TOP2A DYNC1H1 | 3.75e-04 | 591 | 146 | 13 | int:SUMO2 |
| Interaction | KRT8 interactions | MYH1 DENND4A DCDC1 CEP162 STXBP4 OBSL1 ANKRD26 MAPK14 ALMS1 DIAPH3 DMD | 3.77e-04 | 441 | 146 | 11 | int:KRT8 |
| Interaction | XRCC5 interactions | NDST1 HYOU1 SPTA1 OBSL1 HNRNPA1 LIG4 TXLNA SAFB DNAJC9 POLL TOP2A DYNC1H1 | 3.79e-04 | 515 | 146 | 12 | int:XRCC5 |
| Interaction | ARRB1 interactions | 3.82e-04 | 304 | 146 | 9 | int:ARRB1 | |
| Interaction | ADRB1 interactions | 3.88e-04 | 20 | 146 | 3 | int:ADRB1 | |
| Interaction | SNRPB interactions | SRSF4 LEO1 OBSL1 HNRNPA1 RBM25 SAFB MAPK14 TLN1 ACIN1 MACF1 SF3B2 DYNC1H1 | 3.92e-04 | 517 | 146 | 12 | int:SNRPB |
| Interaction | FUS interactions | SRSF4 LEO1 ANXA5 NUMA1 OBSL1 HNRNPA1 DDX1 ITK TXLNA RBM25 SAFB ACIN1 SF3B2 HSPA9 DYNC1H1 | 4.02e-04 | 757 | 146 | 15 | int:FUS |
| Interaction | CENPA interactions | LEO1 CENPB SRBD1 CDCA2 TAF3 SMARCA1 DNAJC9 UTP20 DIAPH3 TOP2A | 4.33e-04 | 377 | 146 | 10 | int:CENPA |
| Interaction | GFUS interactions | 4.35e-04 | 49 | 146 | 4 | int:GFUS | |
| Interaction | KCTD13 interactions | EPS8 MYH6 HYOU1 LRCH2 SPTA1 SH3GL1 MYO18A BCR HNRNPA1 DDX1 GPD1L DST TTC7B SACS TLN1 MACF1 LIMCH1 DMD PLEKHA7 HSPA1L HSPA9 DYNC1H1 | 4.47e-04 | 1394 | 146 | 22 | int:KCTD13 |
| Interaction | ZBTB2 interactions | SRSF4 CENPB SH3GL1 NUMA1 SAFB TLN1 SMARCA1 DNAJC9 ACIN1 SF3B2 TOP2A | 4.47e-04 | 450 | 146 | 11 | int:ZBTB2 |
| Interaction | CDH1 interactions | DAB2IP GIPC1 SH3GL1 EFR3A DST YKT6 TLN1 PAK2 MACF1 LIMCH1 DIAPH3 PLEKHA7 HSPA9 TOP2A RAD17 | 4.68e-04 | 768 | 146 | 15 | int:CDH1 |
| Interaction | CSNK1A1 interactions | 4.70e-04 | 381 | 146 | 10 | int:CSNK1A1 | |
| Interaction | CUL4A interactions | DAB2IP HYOU1 KMT5A ANXA5 SPTA1 ANXA7 NUMA1 DDX1 GPD1L SMC3 SCFD1 TMCO3 DMD HSPA1L SF3B2 HSPA9 | 4.75e-04 | 854 | 146 | 16 | int:CUL4A |
| Interaction | CHMP4C interactions | HYOU1 SRSF4 CEP162 SH3GL3 MYO18A HSP90AA5P RBM25 SAFB WDR87 ACIN1 MACF1 HSPA1L HSPA9 TOP2A | 4.79e-04 | 687 | 146 | 14 | int:CHMP4C |
| Interaction | KIF23 interactions | OBSL1 HNRNPA1L2 HSP90AA5P HNRNPA1 CBS DDX1 EFR3A TXLNA RBM25 SAFB ALMS1 ACIN1 MACF1 DMD HEATR5B SF3B2 TOP2A DYNC1H1 | 4.83e-04 | 1031 | 146 | 18 | int:KIF23 |
| Interaction | HNRNPA1 interactions | SRSF4 MRPL47 NBEAL1 ANXA5 NUMA1 DNAH2 OBSL1 HNRNPA1L2 NEB HNRNPA1 DDX1 LIG4 SAFB NAA20 ACIN1 SF3B2 HSPA9 | 4.99e-04 | 945 | 146 | 17 | int:HNRNPA1 |
| Interaction | BMX interactions | 4.99e-04 | 90 | 146 | 5 | int:BMX | |
| Interaction | RAD18 interactions | SRSF4 LEO1 AXL DDX1 SAFB SMARCA1 DNAJC9 ACIN1 HSPA9 TOP2A DYNC1H1 | 5.09e-04 | 457 | 146 | 11 | int:RAD18 |
| Cytoband | 10p12.1 | 1.58e-04 | 32 | 150 | 3 | 10p12.1 | |
| GeneFamily | Myosin heavy chains | 1.64e-08 | 15 | 104 | 5 | 1098 | |
| GeneFamily | Dyneins, axonemal | 2.32e-06 | 17 | 104 | 4 | 536 | |
| GeneFamily | Myosins, class XVIII | 3.28e-05 | 2 | 104 | 2 | 1107 | |
| GeneFamily | N-BAR domain containing | 3.92e-05 | 12 | 104 | 3 | 1289 | |
| GeneFamily | Heat shock 70kDa proteins | 1.19e-04 | 17 | 104 | 3 | 583 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.97e-04 | 8 | 104 | 2 | 939 | |
| GeneFamily | Doublecortin superfamily | 1.43e-03 | 10 | 104 | 2 | 1369 | |
| GeneFamily | Mitogen-activated protein kinases | 2.45e-03 | 13 | 104 | 2 | 651 | |
| GeneFamily | Annexins|Endogenous ligands | 2.45e-03 | 13 | 104 | 2 | 404 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | MYH1 NDST1 MYH6 CES1 HNRNPA1L2 HNRNPA1 POSTN MACF1 KDR LIMCH1 TOP2A EPHA5 | 9.43e-06 | 444 | 149 | 12 | MM1051 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.28e-05 | 90 | 149 | 6 | M39250 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | DNAH3 CES1 CETN2 CEP162 ANXA5 IFT81 DZIP1L DNAH2 ANKRD26 LAMC2 DNAH1 IFTAP ALMS1 NAA20 CEP83 RPGR DMD DNAH5 CFAP46 | 1.48e-05 | 1093 | 149 | 19 | M41649 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS8 KDM5A EFR3A IBTK MAPK14 DST SACS SMC3 SMARCA1 MACF1 UTP20 RPGR DMD ASCC3 TOP2A FILIP1L | 3.11e-05 | 856 | 149 | 16 | M4500 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | MYH1 NDST1 MYH6 CES1 HNRNPA1L2 POSTN MACF1 KDR LIMCH1 TOP2A EPHA5 | 3.13e-05 | 422 | 149 | 11 | M7396 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 3.19e-05 | 32 | 149 | 4 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 4.07e-05 | 34 | 149 | 4 | M45005 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | 6.53e-05 | 379 | 149 | 10 | M1885 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | DCDC1 CES1 CEP162 IFT81 DZIP1L DNAH1 CCDC13 ALMS1 MACF1 DNAH5 CFAP46 | 6.66e-05 | 459 | 149 | 11 | M39136 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | BDP1 EPS8 ANK1 MRPL47 AXL CCDC186 SH3GL3 DNAH2 ANKRD26 DDX1 CDCA2 POSTN TAF3 ALMS1 CEP83 MACF1 LIMCH1 DMD SEMA3E FILIP1L EPHA5 | 3.94e-06 | 978 | 147 | 21 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | LRCH2 LEO1 MRPL47 CCDC186 STXBP4 IFT81 SH3GL3 ANKRD26 CDCA2 LIG4 RBM25 IFTAP ALMS1 SMC3 CEP83 DNAJC9 MASTL MACF1 ZMYM1 RPGR TOP2A FILIP1L RAD17 | 1.46e-05 | 1241 | 147 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.26e-05 | 129 | 147 | 7 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | BDP1 CCDC186 STXBP4 RBM25 TTC7B CEP83 MACF1 LIMCH1 RPGR FILIP1L | 4.46e-05 | 298 | 147 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 CCDC186 STXBP4 TAF3 CATSPER1 TTC7B SMC3 CEP83 MACF1 ZMYM1 HEATR5B FILIP1L | 4.87e-05 | 432 | 147 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DENND4A LEO1 STXBP4 DNAH2 ANKRD26 NEB RBM25 SAFB NSUN3 DST ALMS1 SMC3 CEP83 DMD EPHA5 | 5.01e-05 | 654 | 147 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 CEP162 STXBP4 ANKRD26 SAFB CATSPER1 ALMS1 SMC3 CEP83 RPGR | 6.37e-05 | 311 | 147 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | LRCH2 LEO1 MRPL47 CCDC186 STXBP4 IFT81 SH3GL3 ANKRD26 CDCA2 POSTN LIG4 RBM25 IFTAP ALMS1 SMC3 CEP83 DNAJC9 MASTL MACF1 ZMYM1 RPGR TOP2A FILIP1L RAD17 | 7.04e-05 | 1468 | 147 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 KDM5A STXBP4 RBM25 MAPK14 DST TTC7B ALMS1 SMC3 CEP83 DNAJC9 HEATR5B | 1.06e-04 | 469 | 147 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.17e-04 | 271 | 147 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | LYRM7 BDP1 LRCH2 LEO1 MRPL47 STXBP4 IFT81 ANKRD26 CDCA2 LIG4 RBM25 ALMS1 SMC3 CEP83 DNAJC9 MASTL MACF1 UTP20 RPGR DMD TOP2A | 1.56e-04 | 1257 | 147 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | BDP1 ANK1 MRPL47 CCDC186 DNAH2 ANKRD26 TAF3 ALMS1 CEP83 MACF1 LIMCH1 FILIP1L | 1.66e-04 | 492 | 147 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_500 | 1.90e-04 | 120 | 147 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-08 | 184 | 149 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-08 | 184 | 149 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-08 | 184 | 149 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-07 | 169 | 149 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.52e-07 | 177 | 149 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-07 | 178 | 149 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-07 | 194 | 149 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.18e-07 | 195 | 149 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 3.31e-07 | 196 | 149 | 8 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-07 | 197 | 149 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.58e-07 | 198 | 149 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-06 | 169 | 149 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-06 | 169 | 149 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-06 | 170 | 149 | 7 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 176 | 149 | 7 | 98814f0a67411b2f7b25dc489b2aadb77f45a853 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 176 | 149 | 7 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-06 | 177 | 149 | 7 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-06 | 181 | 149 | 7 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-06 | 181 | 149 | 7 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-06 | 185 | 149 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.04e-06 | 185 | 149 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.27e-06 | 187 | 149 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-06 | 187 | 149 | 7 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 3.75e-06 | 191 | 149 | 7 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-06 | 193 | 149 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.02e-06 | 193 | 149 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 4.16e-06 | 194 | 149 | 7 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 194 | 149 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-06 | 194 | 149 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.30e-06 | 195 | 149 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.30e-06 | 195 | 149 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.45e-06 | 196 | 149 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.45e-06 | 196 | 149 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.45e-06 | 196 | 149 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 196 | 149 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.45e-06 | 196 | 149 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.60e-06 | 197 | 149 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.76e-06 | 198 | 149 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.92e-06 | 199 | 149 | 7 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 199 | 149 | 7 | 99778178e3ec121802db938db8c5475d19b43fec | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.08e-06 | 200 | 149 | 7 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 161 | 149 | 6 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.85e-05 | 163 | 149 | 6 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.85e-05 | 163 | 149 | 6 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 164 | 149 | 6 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 167 | 149 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 171 | 149 | 6 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 171 | 149 | 6 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-05 | 175 | 149 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.75e-05 | 175 | 149 | 6 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 175 | 149 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.75e-05 | 175 | 149 | 6 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.75e-05 | 175 | 149 | 6 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 175 | 149 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 2.75e-05 | 105 | 149 | 5 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 176 | 149 | 6 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-05 | 176 | 149 | 6 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-05 | 176 | 149 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.84e-05 | 176 | 149 | 6 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-05 | 178 | 149 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-05 | 179 | 149 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 180 | 149 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.22e-05 | 180 | 149 | 6 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.43e-05 | 182 | 149 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class （2021.01.30） | 3.54e-05 | 183 | 149 | 6 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 184 | 149 | 6 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.65e-05 | 184 | 149 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-05 | 185 | 149 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-05 | 185 | 149 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.87e-05 | 186 | 149 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 186 | 149 | 6 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 186 | 149 | 6 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 186 | 149 | 6 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 3.87e-05 | 186 | 149 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 113 | 149 | 5 | 6f270b7e59c18243e876311df721e948ce21e850 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.99e-05 | 187 | 149 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue | 3.99e-05 | 187 | 149 | 6 | 61d346c9873c2edb3ce224a0c063c54d9a68309e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 187 | 149 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.11e-05 | 188 | 149 | 6 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-05 | 188 | 149 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.11e-05 | 188 | 149 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.23e-05 | 189 | 149 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.23e-05 | 189 | 149 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-05 | 190 | 149 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.36e-05 | 190 | 149 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.49e-05 | 191 | 149 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.49e-05 | 191 | 149 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-05 | 191 | 149 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.49e-05 | 191 | 149 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.49e-05 | 191 | 149 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.49e-05 | 191 | 149 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 4.49e-05 | 191 | 149 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-05 | 191 | 149 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.49e-05 | 191 | 149 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| Drug | purealin | 4.05e-09 | 58 | 149 | 8 | CID006419303 | |
| Drug | formycin triphosphate | 4.06e-08 | 51 | 149 | 7 | CID000122274 | |
| Drug | S-(-)-Etomoxir | 3.12e-07 | 100 | 149 | 8 | CID000060765 | |
| Drug | clenbuterol | 4.12e-07 | 142 | 149 | 9 | CID000002783 | |
| Drug | B0683 | 1.04e-06 | 117 | 149 | 8 | CID006398969 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.44e-06 | 189 | 149 | 9 | 1045_DN | |
| Drug | wartmannin | MYH1 MYH2 MYH6 MYH7 MYH8 AXL ANXA5 MYO18A ITK JAK3 LIG4 BMX MAPK14 PAK2 KDR MYO18B MAPK13 RAD17 | 6.25e-06 | 811 | 149 | 18 | CID000005691 |
| Drug | Biliton | 6.95e-06 | 41 | 149 | 5 | CID000002974 | |
| Drug | fast white | 7.85e-06 | 42 | 149 | 5 | CID000024008 | |
| Drug | LY294002 | MYH1 MYH2 MYH6 MYH7 MYH8 AXL CEP162 ANXA5 MYO18A BCR JAK3 SAFB MAPK14 PAK2 KDR MAPK13 RAD17 | 8.47e-06 | 748 | 149 | 17 | CID000003973 |
| Drug | blebbistatin | 1.15e-05 | 116 | 149 | 7 | CID003476986 | |
| Drug | oxovanadium | 1.43e-05 | 120 | 149 | 7 | CID000024411 | |
| Drug | plakin | 1.65e-05 | 82 | 149 | 6 | CID000018752 | |
| Drug | pyrophosphate | ACP6 MYH1 MYH2 MYH6 MYH7 MYH8 MYO18A NUDT13 CBS PRTFDC1 POLR3G POLR1D LIG4 POLL MYO18B | 2.67e-05 | 654 | 149 | 15 | CID000001023 |
| Drug | NSC339663 | 4.12e-05 | 250 | 149 | 9 | CID000003892 | |
| Drug | AC1L9INI | 4.23e-05 | 59 | 149 | 5 | CID000445839 | |
| Drug | AMHA | 4.25e-05 | 2 | 149 | 2 | CID000153443 | |
| Drug | candesartan cilexetil | 4.85e-05 | 145 | 149 | 7 | CID000002540 | |
| Drug | trifluoperazine | 5.65e-05 | 324 | 149 | 10 | CID000005566 | |
| Disease | myopathy (implicated_via_orthology) | 8.00e-11 | 48 | 143 | 8 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.16e-10 | 10 | 143 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.92e-09 | 12 | 143 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.92e-09 | 12 | 143 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.11e-09 | 13 | 143 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 7.20e-09 | 15 | 143 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 7.86e-07 | 206 | 143 | 9 | C0152013 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.61e-06 | 80 | 143 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 1.71e-05 | 32 | 143 | 4 | C0345958 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.51e-05 | 71 | 143 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 6.75e-05 | 45 | 143 | 4 | C0278701 | |
| Disease | Cardiomyopathy, Dilated | 8.72e-05 | 48 | 143 | 4 | C0007193 | |
| Disease | response to methotrexate, neurotoxicity | 1.02e-04 | 19 | 143 | 3 | EFO_0011057, GO_0031427 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.02e-04 | 50 | 143 | 4 | C1449563 | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 1.39e-04 | 4 | 143 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.39e-04 | 4 | 143 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.39e-04 | 4 | 143 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 1.39e-04 | 4 | 143 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.39e-04 | 4 | 143 | 2 | 192600 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 2.31e-04 | 5 | 143 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 2.31e-04 | 5 | 143 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 2.31e-04 | 5 | 143 | 2 | C0221409 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 2.31e-04 | 5 | 143 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 2.31e-04 | 5 | 143 | 2 | C0917713 | |
| Disease | colipase measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0801485 | |
| Disease | Muscular Dystrophy, Duchenne | 3.45e-04 | 6 | 143 | 2 | C0013264 | |
| Disease | uterine fibroid | 4.33e-04 | 199 | 143 | 6 | EFO_0000731 | |
| Disease | anxiety, vitamin D measurement | 4.82e-04 | 7 | 143 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 4.82e-04 | 7 | 143 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 4.82e-04 | 7 | 143 | 2 | C0597124 | |
| Disease | Squamous cell carcinoma of lung | 4.99e-04 | 32 | 143 | 3 | C0149782 | |
| Disease | optic disc size measurement | 5.07e-04 | 205 | 143 | 6 | EFO_0004832 | |
| Disease | plasma betaine measurement | 5.97e-04 | 34 | 143 | 3 | EFO_0007787 | |
| Disease | Hereditary spherocytosis | 6.41e-04 | 8 | 143 | 2 | C0037889 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 7.21e-04 | 145 | 143 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 8.21e-04 | 9 | 143 | 2 | C0949658 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.02e-03 | 10 | 143 | 2 | cv:C5675009 | |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 1.25e-03 | 11 | 143 | 2 | 146110 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 1.25e-03 | 11 | 143 | 2 | cv:C0342384 | |
| Disease | cryptorchidism (biomarker_via_orthology) | 1.25e-03 | 11 | 143 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 1.28e-03 | 44 | 143 | 3 | C0340427 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.43e-03 | 169 | 143 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Drug-induced depressive state | 1.49e-03 | 12 | 143 | 2 | C0338715 | |
| Disease | hemolysis | 1.55e-03 | 47 | 143 | 3 | EFO_0009473 | |
| Disease | Primary Ciliary Dyskinesia | 1.55e-03 | 47 | 143 | 3 | C4551720 | |
| Disease | Malformations of Cortical Development | 2.04e-03 | 14 | 143 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.04e-03 | 14 | 143 | 2 | C0431380 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.35e-03 | 15 | 143 | 2 | C0428908 | |
| Disease | behavioural inhibitory control measurement | 2.68e-03 | 16 | 143 | 2 | EFO_0008467 | |
| Disease | response to efavirenz, virologic response measurement | 2.83e-03 | 58 | 143 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 DENND4A ANK1 AXL STXBP4 SPTA1 NEB HNRNPA1 OR10X1 RPRD1A MCUR1 PAK2 MACF1 | 2.85e-03 | 1105 | 143 | 13 | EFO_0004528 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.27e-03 | 61 | 143 | 3 | C1961102 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 3.39e-03 | 18 | 143 | 2 | C0342384 | |
| Disease | cystatin C measurement | 3.55e-03 | 402 | 143 | 7 | EFO_0004617 | |
| Disease | Cardiomyopathies | 3.75e-03 | 130 | 143 | 4 | C0878544 | |
| Disease | Chronic myeloproliferative disorder | 3.78e-03 | 19 | 143 | 2 | C1292778 | |
| Disease | Omenn Syndrome | 3.78e-03 | 19 | 143 | 2 | C2700553 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 4.18e-03 | 20 | 143 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | Severe Combined Immunodeficiency | 4.18e-03 | 20 | 143 | 2 | C0085110 | |
| Disease | Parkinson's disease (is_marker_for) | 4.26e-03 | 67 | 143 | 3 | DOID:14330 (is_marker_for) | |
| Disease | susceptibility to mononucleosis measurement | 4.62e-03 | 69 | 143 | 3 | EFO_0008403 | |
| Disease | Profound Mental Retardation | 4.75e-03 | 139 | 143 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.75e-03 | 139 | 143 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.75e-03 | 139 | 143 | 4 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRKMAELEEVTLDGK | 56 | Q9UKV3 | |
| LKEGASEEEIRLSKM | 481 | P23141 | |
| GKMETDLKEIREEIS | 1221 | A6H8Y1 | |
| DEASLMISREKDTLG | 1491 | A6H8Y1 | |
| IKELEDLKRTFKEGM | 481 | Q7Z3E2 | |
| DLKRTFKEGMDELRT | 486 | Q7Z3E2 | |
| KEVASEGTMLKRLIE | 711 | Q8NEC5 | |
| MLKRLVSALIGEEKE | 426 | Q5JQC9 | |
| KASELDLEKGLEMRK | 486 | P11274 | |
| MDTKSILEELLLKRS | 1 | P51813 | |
| MDEELGSLEELEKKR | 1036 | P16157 | |
| ESFTELDLGDRVMKL | 181 | P54756 | |
| LTIDDTKRAGMKELK | 816 | Q96GX5 | |
| AKTLKEIRTLLMEAE | 2256 | Q8TCU4 | |
| LLKEMDDGLLEIERK | 1756 | Q8IYW2 | |
| TELAATMVELGKDKR | 281 | O14908 | |
| DAIRDAEILRKAMKG | 186 | P20073 | |
| KETEGLRQEMSKDLE | 101 | P02647 | |
| LRGELVEKTKDLEEM | 91 | Q9Y592 | |
| KERLLEDSKGVKELM | 2721 | P11532 | |
| DERADAETLRKAMKG | 16 | P08758 | |
| MELRIKDLESELSKI | 1526 | Q9UPS8 | |
| KKRLLEMKTEGDETG | 1046 | Q9NSV4 | |
| GTIDVKELKVAMRAL | 46 | P41208 | |
| DTSGMEEQEKEKRRL | 736 | Q14156 | |
| GKRMAEKIIEILESG | 306 | Q9UGP5 | |
| KVDMDKSGEVRLIEL | 651 | Q7Z401 | |
| DALTDEKERKALEGM | 2251 | Q6ZS30 | |
| IEVIEIMTDRGSGKK | 131 | Q32P51 | |
| IEVIEIMTDRGSGKK | 86 | A0A2R8Y4L2 | |
| LDEETKRRDQMIKGA | 196 | P49756 | |
| DRIERLAKDIMKDIG | 51 | Q9NRG1 | |
| MLGDDLRTDKKIILV | 211 | O75943 | |
| GEARKTEVLLKVMDA | 546 | P52333 | |
| GSLEQEKKVRMDLER | 1036 | P12883 | |
| DTLEEKLESMGIRKD | 461 | Q8IYY4 | |
| VEESELLVVKMDGRK | 756 | O75147 | |
| GIISRLMSVEEELKK | 1101 | Q5VWQ8 | |
| LRSGMEVVLVEKKSD | 1191 | M0R2J8 | |
| VIKVSELDGRKMGDA | 186 | Q9H649 | |
| KMLEDLLAKDRSISV | 96 | Q8NGY0 | |
| GSDSEDEVLRMKRKN | 276 | Q8WVC0 | |
| EEMLDEEGRTRLKLK | 401 | Q8WVC0 | |
| RKIETEVAGLKTMLE | 316 | Q96AQ8 | |
| RIDELIESGKEEGMK | 246 | Q9NQR1 | |
| DVRKELLTKDLRGEM | 346 | Q86U10 | |
| LKLISDIIREKMGID | 131 | Q8N335 | |
| RTGKTIEELEKEMLN | 281 | Q8N335 | |
| DKEGLSALDLVMKDR | 116 | Q9P2D0 | |
| EKMLVLDSDKRITAA | 286 | Q16539 | |
| ETEKKLMSLGDIRLE | 5846 | Q03001 | |
| IIDKSRLKGKEDMVD | 386 | Q9C098 | |
| RLKGKEDMVDSEILI | 391 | Q9C098 | |
| RMGLAISLVATEKEK | 611 | Q92499 | |
| EGQLEELKDSRRVMK | 156 | Q58FG0 | |
| DLEGSLEQEKKLRMD | 1036 | P13535 | |
| KLMELLEEISERKGG | 91 | P61599 | |
| RDTKEEMGELARKEA | 1881 | Q92614 | |
| EMGELARKEAEASRK | 1886 | Q92614 | |
| EGSLEQEKKLRMDLE | 1041 | Q9UKX2 | |
| EGTRMKVEDVKALFD | 326 | P52848 | |
| LMLKKATDETDRDII | 2306 | O94854 | |
| EKMLELDVDKRLTAA | 286 | O15264 | |
| TNDKGRLSKEEIERM | 506 | P34931 | |
| IKELTKEREAMSLEL | 156 | A0A1B0GV03 | |
| DDLEGSLEQEKKIRM | 1036 | P12882 | |
| GREDDIKKSERMTAV | 21 | Q8TAC1 | |
| SKMRELLARKDSETG | 616 | P38646 | |
| EMETELKGSFIELRK | 126 | Q86X67 | |
| LAMGTKDKEDEVTRR | 251 | P29375 | |
| KIEELMKIGSDVELL | 51 | Q5U5X0 | |
| VATMRDLGKKETLEA | 36 | Q9NYR8 | |
| KMSLVKTKEEDGREA | 241 | Q9H813 | |
| LEMDVEKRGSAKELL | 481 | Q13177 | |
| KRLLVESKDTLVEMA | 301 | Q8IYK2 | |
| RMKSGLDKLLRTSED | 2831 | Q9P2D7 | |
| KEKALRIAEELGMDD | 101 | P07199 | |
| EGLMDDVDFKAKVTR | 331 | Q9Y4L1 | |
| ERVSALKSEVDEMKG | 466 | Q8WYA0 | |
| LKSEVDEMKGRTLDD | 471 | Q8WYA0 | |
| SVKRMDKQTEEILGD | 156 | Q86VG3 | |
| KGKMVVSIAEDLLRT | 526 | Q9P2D3 | |
| MSEIRKDTLKAILLE | 1 | Q13325 | |
| GTKFDIKRMVEDSDL | 346 | P49917 | |
| DKKDTTRLDIVDMLL | 2171 | Q8TD57 | |
| RDEVIGILKAEKMDL | 86 | Q4L180 | |
| ELEELKKKFEGMRSR | 341 | Q8IYE1 | |
| DLLSRIDLDELMKKD | 36 | Q8WUF8 | |
| EKMSSEKVDVLRALG | 171 | P35520 | |
| ILGKVKFSDSERTME | 1011 | Q5TEA3 | |
| LEGKDEDAKKSLRTM | 976 | Q5TB80 | |
| EAKEAEMSRKELGLD | 196 | Q8WXX5 | |
| KMDDVSRRLTAEGKD | 91 | Q8N8F7 | |
| GKESEMTDLTRKEGL | 171 | Q69YH5 | |
| KRETGGKEESSLMDL | 246 | Q9Y6I3 | |
| EKEMRVTLAKLLAES | 1706 | Q14204 | |
| LASLKSEMREVEGEL | 1046 | Q13753 | |
| DRKDAMITVDDGIRK | 76 | Q12929 | |
| MITVDDGIRKLKLLD | 81 | Q12929 | |
| RKKSEEMELKLERAG | 3266 | Q9P225 | |
| KDVRELVEKSGDLME | 66 | O00237 | |
| ATLILDSIKRLEMEK | 506 | Q9NZJ4 | |
| KETEMLGEEARELLS | 946 | Q8TE73 | |
| EEIGKLKDLMELDIS | 196 | Q5VUJ6 | |
| KMEKLLAGEDGTSER | 391 | Q9UPQ0 | |
| GESKELKRLVMAESE | 1246 | Q14980 | |
| VELLTRKLEMLGAEK | 21 | Q9H944 | |
| DKVAIKTIREGAMSE | 386 | Q08881 | |
| MRAKELEDKVAEILS | 1111 | A6NES4 | |
| SEGLKKSEEDDMILV | 96 | Q9NQ35 | |
| ETKLAEIAGMKDLRE | 646 | Q92834 | |
| EIAGMKDLREREKST | 651 | Q92834 | |
| MEEDQELERKISGLK | 1 | P0DPB6 | |
| ELERKISGLKTSMAE | 6 | P0DPB6 | |
| MDASIDEVVRKAKLG | 466 | Q5VWG9 | |
| DLRRKGKGMVAEEIE | 866 | O75691 | |
| SDMKRALEKLDGTEV | 151 | Q08170 | |
| RKEESISLMKETEGK | 171 | Q9UQE7 | |
| TILERGEKKTAEMNE | 691 | P28370 | |
| GTKLDDEFLDMERKI | 26 | Q99963 | |
| ITKREVEDDLGLSML | 231 | Q6UWJ1 | |
| EKITGELEEMRKVLE | 296 | Q6ZMZ3 | |
| ELEKLMRGLEAESES | 71 | P0C7N4 | |
| ELEKLMRGLEAESES | 71 | A6NGB0 | |
| LDLKMTGRDLLKDRS | 666 | Q6IQ23 | |
| MAEEGAILKVTKDLR | 1 | Q6ZNE9 | |
| LEGSLEQEKKVRMDL | 1036 | P13533 | |
| RLDKVVDSMDALDKV | 131 | Q9HD33 | |
| ESKELVKSVRALLDM | 481 | Q6ZWJ1 | |
| SFLEKEGMEKIAERL | 861 | Q8N5C6 | |
| VLMERLKKAIEDEGG | 56 | Q15424 | |
| EERLMKEVEQLASKG | 311 | Q8TDG2 | |
| LTVDKLKDMRKDEIG | 1146 | Q8N3C0 | |
| TMESLLERGEKLDDL | 156 | O15498 | |
| AEIEGTMRKKLSLDE | 376 | O60296 | |
| LRKKKIEEAMDGSET | 766 | Q13435 | |
| LDGRKESEALVKLME | 101 | Q6NUS8 | |
| MKRLAEVKDSLDIEV | 121 | Q99961 | |
| GDKEMAEAISELRLS | 551 | Q70EL2 | |
| DKITDKESGERLSKM | 201 | Q96P16 | |
| DGAEKQLREILTMEK | 46 | Q8NBT2 | |
| AMKIKVGSDDLERIE | 716 | Q9BQI7 | |
| GTKLDDDFKEMERKV | 26 | Q99962 | |
| RELMEEKKEEITGTL | 131 | Q9Y490 | |
| LGISEELKEKLRDVM | 516 | P30530 | |
| QEDEVKRLKSIMGLE | 351 | Q8WVM8 | |
| DLKKVKDRMGIDSSD | 231 | Q9NPH0 | |
| VLKKMEELEKRGDGE | 141 | O15318 | |
| LDSLEALMKKRDDLD | 1426 | P02549 | |
| LKKLMSTSEGIDERK | 1281 | Q8IUG5 | |
| KMTEEKLAEAERVGL | 971 | P11388 | |
| RVALEDVLKDDKMGL | 456 | Q96NZ8 | |
| MATKKAGSRLETEIE | 1 | Q86TV6 | |
| VKTDDRVVKMDLGLL | 626 | O15041 | |
| GMVLASEELKTLEDR | 1261 | P35968 | |
| FLELLEMRAKDKGEE | 586 | Q5SVZ6 | |
| FKGMTSEEKEILIRD | 541 | Q15063 | |
| IEVIEIMTDRGSGKK | 131 | P09651 | |
| AEEKMRLVEGKETLS | 1971 | Q6ZQQ6 | |
| DRILAMEESEIAKGK | 2021 | Q6ZQQ6 | |
| MEESEIAKGKLEFTR | 2026 | Q6ZQQ6 | |
| MAEEKTVRDKELEGL | 446 | P40222 | |
| VLKASREEKVLMDEG | 226 | Q5T7N2 | |
| KDLEESIRGKGLTEM | 5976 | P20929 |